• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于 HLA 抗体检测的固相多重微球芯片的全面评估和标准化

Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.

机构信息

Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, CA, USA.

出版信息

Am J Transplant. 2013 Jul;13(7):1859-70. doi: 10.1111/ajt.12287. Epub 2013 Jun 13.

DOI:10.1111/ajt.12287
PMID:23763485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3967448/
Abstract

Solid phase multiplex-bead arrays for the detection and characterization of HLA antibodies provide increased sensitivity and specificity compared to conventional lymphocyte-based assays. Assay variability due to inconsistencies in commercial kits and differences in standard operating procedures (SOP) hamper comparison of results between laboratories. The Clinical Trials in Organ Transplantation Antibody Core Laboratories investigated sources of assay variation and determined if reproducibility improved through utilization of SOP, common reagents and normalization algorithms. Ten commercial kits from two manufacturers were assessed in each of seven laboratories using 20 HLA reference sera. Implementation of a standardized (vs. a nonstandardized) operating procedure greatly reduced MFI variation from 62% to 25%. Although laboratory agreements exceeded 90% (R(2) ), small systematic differences were observed suggesting center specific factors still contribute to variation. MFI varied according to manufacturer, kit, bead type and lot. ROC analyses showed excellent consistency in antibody assignments between manufacturers (AUC > 0.9) and suggested optimal cutoffs from 1000 to 1500 MFI. Global normalization further reduced MFI variation to levels near 20%. Standardization and normalization of solid phase HLA antibody tests will enable comparison of data across laboratories for clinical trials and diagnostic testing.

摘要

固相多重珠阵列用于检测和鉴定 HLA 抗体,与传统的基于淋巴细胞的检测方法相比,具有更高的灵敏度和特异性。由于商业试剂盒的不一致性和标准操作程序 (SOP) 的差异,检测的变异性妨碍了实验室之间结果的比较。器官移植抗体临床试验核心实验室研究了检测变异性的来源,并确定通过使用 SOP、共同试剂和归一化算法是否可以提高重现性。使用 20 个 HLA 参考血清,在七个实验室中的每个实验室中评估了来自两个制造商的十种商业试剂盒。实施标准化(而非非标准化)操作程序可将 MFI 变化从 62%大幅降低至 25%。尽管实验室间的一致性超过 90%(R(2)),但仍观察到一些小的系统差异,表明中心特定因素仍会导致变异性。MFI 因制造商、试剂盒、珠类型和批次而异。ROC 分析表明,制造商之间的抗体分配具有极好的一致性(AUC > 0.9),并建议使用 1000 至 1500 MFI 的最佳截止值。全局归一化进一步将 MFI 变化降低至接近 20%的水平。固相 HLA 抗体检测的标准化和归一化将使临床试验和诊断检测的实验室间数据比较成为可能。

相似文献

1
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.用于 HLA 抗体检测的固相多重微球芯片的全面评估和标准化
Am J Transplant. 2013 Jul;13(7):1859-70. doi: 10.1111/ajt.12287. Epub 2013 Jun 13.
2
Solid-phase bead-based assays limitations are not restricted to interlaboratory variability.基于珠粒的固相分析的局限性并不局限于实验室间的可变性。
Am J Transplant. 2013 Nov;13(11):3049. doi: 10.1111/ajt.12463. Epub 2013 Oct 1.
3
Inter and intra laboratory concordance of HLA antibody results obtained by single antigen bead based assay.基于单抗原珠检测的 HLA 抗体检测结果的实验室间和实验室内一致性。
Hum Immunol. 2013 Mar;74(3):310-7. doi: 10.1016/j.humimm.2012.12.003. Epub 2012 Dec 10.
4
How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?如何降低固相多重微球检测法测定抗 HLA 抗体的成本?
HLA. 2016 Sep;88(3):110-9. doi: 10.1111/tan.12860. Epub 2016 Aug 18.
5
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation.用于检测抗人白细胞抗原(HLA)抗体的固相多重微珠阵列的综合评估与标准化——深入探究关键变异来源
Am J Transplant. 2013 Nov;13(11):3050-1. doi: 10.1111/ajt.12462. Epub 2013 Sep 18.
6
Clinical cytometry and progress in HLA antibody detection.临床细胞计数法与人类白细胞抗原抗体检测进展
Methods Cell Biol. 2011;103:285-310. doi: 10.1016/B978-0-12-385493-3.00012-7.
7
Strategies for human leukocyte antigen antibody detection.人类白细胞抗原抗体检测策略。
Curr Opin Organ Transplant. 2009 Aug;14(4):392-7. doi: 10.1097/mot.0b013e32832d31c7.
8
Improved flow cytometry based cytotoxicity and binding assay for clinical antibody HLA crossmatching.用于临床抗体HLA交叉配型的基于流式细胞术的改进细胞毒性和结合测定法。
Hum Immunol. 2015 Nov;76(11):849-57. doi: 10.1016/j.humimm.2015.09.047. Epub 2015 Sep 30.
9
Reassessment of T Lymphocytes Crossmatches Results Prediction With Luminex Class I Single Antigen Flow Beads Assay.使用Luminex I类单抗原流式微球分析法对T淋巴细胞交叉配型结果预测的重新评估
Transplantation. 2017 Mar;101(3):624-630. doi: 10.1097/TP.0000000000001239.
10
Interlaboratory Comparison of the Results of Lifecodes LSA Class I and Class II Single Antigen Kits for Human Leukocyte Antigen Antibody Detection.用于人类白细胞抗原抗体检测的Lifecodes LSA I类和II类单抗原试剂盒结果的实验室间比较。
Ann Lab Med. 2015 May;35(3):321-8. doi: 10.3343/alm.2015.35.3.321. Epub 2015 Apr 1.

引用本文的文献

1
Early Donor-Specific HLA Antibodies Detected by Screening in the First Month Posttransplant and Kidney Graft Outcomes.移植后第一个月筛查发现的早期供体特异性 HLA 抗体与肾移植结局
Transpl Int. 2025 Aug 6;38:14424. doi: 10.3389/ti.2025.14424. eCollection 2025.
2
Desensitization in HLA-incompatible kidney transplant recipients: current strategies and emerging perspectives.HLA不相合肾移植受者的脱敏治疗:当前策略与新观点
Clin Kidney J. 2025 Jul 9;18(8):sfaf219. doi: 10.1093/ckj/sfaf219. eCollection 2025 Aug.
3
Luminex MFI-Efforts from a Qualitative to a Quantitative Analysis.

本文引用的文献

1
HLA antibody profiling in thoracic transplantation undergoing desensitization therapy.在进行脱敏治疗的胸移植中 HLA 抗体分析。
Curr Opin Organ Transplant. 2012 Aug;17(4):416-22. doi: 10.1097/MOT.0b013e328355f1ab.
2
The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.供者特异性抗 HLA 抗体对晚期肾移植失败的影响。
Nat Rev Nephrol. 2012 Apr 17;8(6):348-57. doi: 10.1038/nrneph.2012.81.
3
Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.
Luminex平均荧光强度——从定性分析到定量分析的努力
Biology (Basel). 2025 Jun 12;14(6):686. doi: 10.3390/biology14060686.
4
Comprehensive analysis of human coronavirus antibody responses in ICU and non-ICU COVID-19 patients reveals IgG3 against SARS-CoV-2 spike protein as a key biomarker of disease severity.对ICU和非ICU新冠肺炎患者的人类冠状病毒抗体反应进行的综合分析显示,针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的IgG3是疾病严重程度的关键生物标志物。
J Med Microbiol. 2025 May;74(5). doi: 10.1099/jmm.0.002012.
5
Surveillance donor-specific antibody and pathologic antibody-mediated rejection testing in heart transplant patients in the contemporary era.当代心脏移植患者中监测供体特异性抗体及病理抗体介导的排斥反应检测
J Heart Lung Transplant. 2025 Jul;44(7):1036-1049. doi: 10.1016/j.healun.2025.01.019. Epub 2025 Feb 4.
6
Evaluation of donor specific antibodies after kidney transplantation in the era of donor-derived cell-free DNA.供体来源游离DNA时代肾移植后供体特异性抗体的评估
Front Immunol. 2025 Jan 16;15:1530065. doi: 10.3389/fimmu.2024.1530065. eCollection 2024.
7
Anti-Human Leukocyte Antigen Antibody Detection from Terasaki's Humoral Theory to Delisting Strategies in 2024.从寺崎的体液理论到2024年退市策略的抗人白细胞抗原抗体检测
Int J Mol Sci. 2025 Jan 13;26(2):630. doi: 10.3390/ijms26020630.
8
HLA class, calcineurin inhibitor levels, and the risk of graft failure in kidney recipients with donor-specific antibodies.HLA类别、钙调神经磷酸酶抑制剂水平与存在供体特异性抗体的肾移植受者的移植失败风险
Front Immunol. 2024 Nov 20;15:1493878. doi: 10.3389/fimmu.2024.1493878. eCollection 2024.
9
Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development.同种异体 HLA 的体液免疫原性及供体特异性 HLA 抗体产生的预测
Antibodies (Basel). 2024 Jul 24;13(3):61. doi: 10.3390/antib13030061.
10
Perspective for Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection After Kidney Transplantation: Defining Context of Use and Clinical Implications.供体来源无细胞 DNA 在肾移植后抗体介导排斥反应中的作用:定义使用范围和临床意义。
Transpl Int. 2024 Aug 12;37:13239. doi: 10.3389/ti.2024.13239. eCollection 2024.
移植后供者特异性 HLA 抗体的新出现与临床病理相关性的演变。
Am J Transplant. 2012 May;12(5):1157-67. doi: 10.1111/j.1600-6143.2012.04013.x. Epub 2012 Mar 19.
4
Banff 2011 Meeting report: new concepts in antibody-mediated rejection.班夫 2011 年会报告:抗体介导排斥反应的新概念。
Am J Transplant. 2012 Mar;12(3):563-70. doi: 10.1111/j.1600-6143.2011.03926.x. Epub 2012 Feb 2.
5
HLA antibody specification using single-antigen beads--a technical solution for the prozone effect.使用单抗原珠进行 HLA 抗体特异性检测--解决前带效应的技术方案。
Transplantation. 2011 Sep 15;92(5):510-5. doi: 10.1097/TP.0b013e31822872dd.
6
Desensitization in HLA-incompatible kidney recipients and survival.HLA 不相容的肾移植受者的脱敏治疗与生存。
N Engl J Med. 2011 Jul 28;365(4):318-26. doi: 10.1056/NEJMoa1012376.
7
High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant.高平均荧光强度供体特异性抗 HLA 抗体与肝移植后慢性排斥反应相关。
Am J Transplant. 2011 Sep;11(9):1868-76. doi: 10.1111/j.1600-6143.2011.03593.x. Epub 2011 Jun 14.
8
Quantifying HLA-specific antibodies in patients undergoing desensitization.定量检测脱敏治疗患者的 HLA 特异性抗体。
Curr Opin Organ Transplant. 2011 Aug;16(4):410-5. doi: 10.1097/MOT.0b013e32834899b8.
9
Report from a consensus conference on antibody-mediated rejection in heart transplantation.心脏移植中抗体介导排斥反应的共识会议报告。
J Heart Lung Transplant. 2011 Mar;30(3):252-69. doi: 10.1016/j.healun.2010.11.003.
10
Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay.在单抗原微珠检测时代对阳性流式细胞交叉配型的解读。
Transplantation. 2011 Mar 15;91(5):527-35. doi: 10.1097/TP.0b013e31820794bb.